Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 3/2016

01.03.2016 | Original Article

Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases

verfasst von: Paramin Muangkaew, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The optimal surgical strategy for treating colorectal cancer liver metastases (CRLM) in patients requiring major liver resection (MLR) is controversial, especially in rectal cancer patients.

Method

Between March 2004 and January 2015, 103 patients underwent MLR for CRLM and underwent MLR simultaneously with colorectal surgery (simultaneous group; n = 55) or MLR after colorectal surgery (liver-only group; n = 48).

Results

There were no significant differences in sex, age, ASA score, BMI, size and number of liver metastases, liver resection margin, surgical outcomes, and estimated blood loss. The rates of postoperative complications (simultaneous group vs. liver-only group; 76.4 % vs. 62.5 %; P = 0.126) and major complications (29.0 % vs. 25.0 %; P = 0.513) were also similar in both groups. The time to starting a soft diet was longer in the simultaneous group (6.0 days vs. 3.4 days; P < 0.001), but the length of hospital stay was similar (14.9 days vs. 13.3 days; P = 0.345). There were no perioperative deaths, anastomotic leakage, or septic complications. Among patients who underwent rectal surgery, the frequency of complications was greater in the simultaneous group (87.0 % vs. 56.2 %; P = 0.031), but there was no difference in major complications (34.7 % vs. 25.0 %; P = 0.822). The postoperative morbidity index was 0.204 and 0.180 in the simultaneous and liver-only groups, respectively, in all patients, and was 0.227 and 0.136, respectively, in the rectal surgery subgroup.

Conclusion

Simultaneous MLR is feasible and safe in synchronous CRLM patients, including rectal cancer patients.
Literatur
1.
Zurück zum Zitat Muratore A, Zorzi D, Bouzari H, et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007; 14(2):766–70.CrossRefPubMed Muratore A, Zorzi D, Bouzari H, et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007; 14(2):766–70.CrossRefPubMed
2.
Zurück zum Zitat Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012; 17(10):1225–39.PubMedCentralCrossRefPubMed Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012; 17(10):1225–39.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat de Santibanes E, Fernandez D, Vaccaro C, et al. Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg 2010; 34(9):2133–40.CrossRefPubMed de Santibanes E, Fernandez D, Vaccaro C, et al. Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg 2010; 34(9):2133–40.CrossRefPubMed
4.
Zurück zum Zitat Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004; 136(3):650–9.CrossRefPubMed Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004; 136(3):650–9.CrossRefPubMed
5.
Zurück zum Zitat Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243(1):1–7.PubMedCentralCrossRefPubMed Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243(1):1–7.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236(4):397–406; discussion 406–7.PubMedCentralCrossRefPubMed Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236(4):397–406; discussion 406–7.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Qureshi MS, Goldsmith PJ, Maslekar S, et al. Synchronous resection of colorectal cancer and liver metastases: comparative views of colorectal and liver surgeons. Colorectal Dis 2012; 14(8):e477-85.CrossRefPubMed Qureshi MS, Goldsmith PJ, Maslekar S, et al. Synchronous resection of colorectal cancer and liver metastases: comparative views of colorectal and liver surgeons. Colorectal Dis 2012; 14(8):e477-85.CrossRefPubMed
8.
Zurück zum Zitat Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12(5):351–5.CrossRefPubMed Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12(5):351–5.CrossRefPubMed
9.
Zurück zum Zitat Cho JY, Suh KS, Kwon CH, et al. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139(4):508–15.CrossRefPubMed Cho JY, Suh KS, Kwon CH, et al. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139(4):508–15.CrossRefPubMed
10.
Zurück zum Zitat Cho JY, Suh KS, Kwon CH, et al. Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl 2006; 12(2):201–6.CrossRefPubMed Cho JY, Suh KS, Kwon CH, et al. Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl 2006; 12(2):201–6.CrossRefPubMed
11.
Zurück zum Zitat Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009; 250(2):177–86.CrossRefPubMed Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009; 250(2):177–86.CrossRefPubMed
12.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149(5):713–24.CrossRefPubMed Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149(5):713–24.CrossRefPubMed
13.
Zurück zum Zitat Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010; 147(3):339–51.CrossRefPubMed Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010; 147(3):339–51.CrossRefPubMed
14.
Zurück zum Zitat Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg 2011; 213(5):616–26.CrossRefPubMed Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg 2011; 213(5):616–26.CrossRefPubMed
15.
Zurück zum Zitat Datta J, Lewis RS, Jr., Strasberg SM, et al. Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective. J Gastrointest Surg 2015; 19(3):506–15.CrossRefPubMed Datta J, Lewis RS, Jr., Strasberg SM, et al. Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective. J Gastrointest Surg 2015; 19(3):506–15.CrossRefPubMed
16.
Zurück zum Zitat Mi K, Kalady MF, Quintini C, et al. Integrating systemic and surgical approaches to treating metastatic colorectal cancer. Surg Oncol Clin N Am 2015; 24(1):199–214.CrossRefPubMed Mi K, Kalady MF, Quintini C, et al. Integrating systemic and surgical approaches to treating metastatic colorectal cancer. Surg Oncol Clin N Am 2015; 24(1):199–214.CrossRefPubMed
17.
Zurück zum Zitat Lambert LA, Colacchio TA, Barth RJ, Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000; 135(4):473–9; discussion 479–80.CrossRefPubMed Lambert LA, Colacchio TA, Barth RJ, Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000; 135(4):473–9; discussion 479–80.CrossRefPubMed
18.
Zurück zum Zitat Nakajima K, Takahashi S, Saito N, et al. Predictive factors for anastomotic leakage after simultaneous resection of synchronous colorectal liver metastasis. J Gastrointest Surg 2012; 16(4):821–7.PubMedCentralCrossRefPubMed Nakajima K, Takahashi S, Saito N, et al. Predictive factors for anastomotic leakage after simultaneous resection of synchronous colorectal liver metastasis. J Gastrointest Surg 2012; 16(4):821–7.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231(5):743–51.PubMedCentralCrossRefPubMed Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231(5):743–51.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007; 14(12):3481–91.CrossRefPubMed Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007; 14(12):3481–91.CrossRefPubMed
21.
Zurück zum Zitat Silberhumer GR, Paty PB, Temple LK, et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 2014. Silberhumer GR, Paty PB, Temple LK, et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 2014.
22.
Zurück zum Zitat Weber JC, Bachellier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90(8):956–62.CrossRefPubMed Weber JC, Bachellier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90(8):956–62.CrossRefPubMed
23.
Zurück zum Zitat Capussotti L, Ferrero A, Vigano L, et al. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007; 14(1):195–201.CrossRefPubMed Capussotti L, Ferrero A, Vigano L, et al. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007; 14(1):195–201.CrossRefPubMed
24.
Zurück zum Zitat Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197(2):233–41; discussion 241–2.CrossRefPubMed Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197(2):233–41; discussion 241–2.CrossRefPubMed
25.
Zurück zum Zitat Yoshioka R, Hasegawa K, Mise Y, et al. Evaluation of the safety and efficacy of simultaneous resection of primary colorectal cancer and synchronous colorectal liver metastases. Surgery 2014; 155(3):478–85.CrossRefPubMed Yoshioka R, Hasegawa K, Mise Y, et al. Evaluation of the safety and efficacy of simultaneous resection of primary colorectal cancer and synchronous colorectal liver metastases. Surgery 2014; 155(3):478–85.CrossRefPubMed
26.
Zurück zum Zitat Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 2007; 33 Suppl 2:S35-41.CrossRefPubMed Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 2007; 33 Suppl 2:S35-41.CrossRefPubMed
27.
Zurück zum Zitat Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240(6):1052–61; discussion 1061–4.PubMedCentralCrossRefPubMed Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240(6):1052–61; discussion 1061–4.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003; 7(1):109–15; discussion 116–7.CrossRefPubMed Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003; 7(1):109–15; discussion 116–7.CrossRefPubMed
29.
Zurück zum Zitat Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94(3):274–86.CrossRefPubMed Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94(3):274–86.CrossRefPubMed
30.
Zurück zum Zitat Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 2009; 16(9):2385–90.CrossRefPubMed Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 2009; 16(9):2385–90.CrossRefPubMed
31.
Zurück zum Zitat Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16(8):1311–9.CrossRefPubMed Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16(8):1311–9.CrossRefPubMed
32.
Zurück zum Zitat Pessaux P, Chenard MP, Bachellier P, et al. Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg 2010; 147(4):e193-201.CrossRefPubMed Pessaux P, Chenard MP, Bachellier P, et al. Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg 2010; 147(4):e193-201.CrossRefPubMed
33.
Zurück zum Zitat Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24(13):2065–72.CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24(13):2065–72.CrossRefPubMed
34.
Zurück zum Zitat Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 2008; 34(6):609–14.CrossRefPubMed Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 2008; 34(6):609–14.CrossRefPubMed
35.
Zurück zum Zitat Fernandez FG, Ritter J, Goodwin JW, et al. Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases. Journal of the American College of Surgeons 2005; 200(6):845–853.CrossRefPubMed Fernandez FG, Ritter J, Goodwin JW, et al. Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases. Journal of the American College of Surgeons 2005; 200(6):845–853.CrossRefPubMed
36.
Zurück zum Zitat Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–21.PubMedCentralCrossRefPubMed Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–21.PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Jovine E, Biolchini F, Talarico F, et al. Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis 2007; 9(3):245–52.CrossRefPubMed Jovine E, Biolchini F, Talarico F, et al. Major hepatectomy in patients with synchronous colorectal liver metastases: whether or not a contraindication to simultaneous colorectal and liver resection? Colorectal Dis 2007; 9(3):245–52.CrossRefPubMed
38.
Zurück zum Zitat Yasui K, Shimizu Y. Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 2005; 10(2):86–96.CrossRefPubMed Yasui K, Shimizu Y. Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 2005; 10(2):86–96.CrossRefPubMed
39.
Zurück zum Zitat DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000; 4(2):178–84.CrossRefPubMed DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000; 4(2):178–84.CrossRefPubMed
40.
Zurück zum Zitat Thelen A, Jonas S, Benckert C, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 2007; 22(10):1269–76.CrossRefPubMed Thelen A, Jonas S, Benckert C, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 2007; 22(10):1269–76.CrossRefPubMed
41.
Zurück zum Zitat Abbott AM, Parsons HM, Tuttle TM, et al. Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study. Ann Surg Oncol 2013; 20(1):139–47.CrossRefPubMed Abbott AM, Parsons HM, Tuttle TM, et al. Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study. Ann Surg Oncol 2013; 20(1):139–47.CrossRefPubMed
42.
Zurück zum Zitat Capussotti L, Muratore A, Ferrero A, et al. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 2006; 93(6):685–9.CrossRefPubMed Capussotti L, Muratore A, Ferrero A, et al. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 2006; 93(6):685–9.CrossRefPubMed
43.
Zurück zum Zitat Dello SA, Reisinger KW, van Dam RM, et al. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One 2012; 7(1):e30539.PubMedCentralCrossRefPubMed Dello SA, Reisinger KW, van Dam RM, et al. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One 2012; 7(1):e30539.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24(31):4983–90.CrossRefPubMed Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24(31):4983–90.CrossRefPubMed
Metadaten
Titel
Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases
verfasst von
Paramin Muangkaew
Jai Young Cho
Ho-Seong Han
Yoo-Seok Yoon
YoungRok Choi
Jae Yool Jang
Hanlim Choi
Jae Seong Jang
Seong Uk Kwon
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2016
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2979-9

Weitere Artikel der Ausgabe 3/2016

Journal of Gastrointestinal Surgery 3/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.